Supply Chain Management

Rubrik: Fachthemen

(Treffer aus pharmind, Nr. 09, Seite 1222 (2018))

Müßig R | Frey F | Rehm A | Malbrant S

Supply Chain Management / Part 5: Creating Supply Chain Flexibility through Postponement*Part 1 see Pharm Ind. 2015;77(10):1452–1457; Part 2 see Pharm Ind. 2016;78(9):1270–1275; Part 3 see Pharm Ind. 2016;78(11):1580–1587 and Part 4 see Pharm Ind. 2018;80(7):916–923. · Müßig R¹, Frey F², Rehm A², Malbrant S¹ · ¹Camelot Management Consultants AG, Mannheim und ²Schreiner, Oberschleißheim und MediPharm
The pharmaceutical industry is in a constant state of change. Especially during the last decade, a major transition could be observed: a shift from solely focusing on product developments towards incorporating actual patient needs, leading to additional offerings “beyond the pill”. This will have further implications, particularly in the supply chain area. As already discussed in a previous article by Packowski et al. [ 1 ], companies will have to cope with challenging market developments. Figure 1 provides some examples, such as an increasing share of biotech products, as well as an emerging trend to personalized medicine. Since biotech products ...